NEBIVOLOL
Generic: NEBIVOLOL
Solco Healthcare USManufacturer
ORALRoute
NEBIVOLOLActive Substance
2022-04-07Original Approval
NEBIVOLOL is FDA application ANDA212682, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-12-06
Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-HightstCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolo
Class III2025-11-18
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya PradCross Contamination with Other Products
Top Reported Reactions
1
ACUTE KIDNEY INJURY
1,047 reports
2
DYSPNOEA
909 reports
3
DIARRHOEA
859 reports
4
HYPOTENSION
735 reports
5
NAUSEA
697 reports
6
ANAEMIA
696 reports
7
DRUG INEFFECTIVE
696 reports
8
DRUG INTERACTION
688 reports
9
OFF LABEL USE
674 reports
10
FATIGUE
646 reports